Platinum Equity to acquire LifeScan from Johnson & Johnson for $2.1B

Johnson & Johnson announced a binding offer from Platinum Equity to acquire its LifeScan business for approximately $2.1 billion. LifeScan is a leader in blood glucose monitoring products. The transaction is expected to close by the end of 2018.

“This initiative is part of our ongoing, disciplined approach to portfolio management to focus on our most promising opportunities to help patients and drive growth.”investor.jnj.com

• 1 source
• investor.jnj.comJohnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc. | Johnson & JohnsonMar 16, 2018

Summarized from public sources; check the original articles before acting on it.